Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



β-Caryophyllene causes remyelination and modifies cytokines expression in C57BL/6 mice with Experimental Autoimmune Encephalomyelitis

Harleson Lopes Mesquita,Livia Almeida Fontes,Laetitia Cinsa,Ademar Alves da Silva Filho,Akinori Nagato,Beatriz Julião Aarestrup,José Otávio do Amaral Corrêa,Fernando Monteiro Aarestrup.




Abstract
Cited by 3 Articles

Objectives: To evaluate the effect of β-Caryophyllene (BCP) on the production of IL-17, transcription factors (T-bet, GATA-3) and remyellination in C57BL/6 mice induced for experimental autoimmune encephalomyelitis (EAE), the model for studying pathogenesis and new therapies for multiple sclerosis (MS). Materials and methods: EAE was induced in three groups of C57BL/6, with administration of BCP in two groups (25 and 50 mg/kg/day) by gavage, after the tenth day of induction. At nine days of treatment, mice were euthanized and CNS was removed for the analysis. The profiles of IL-17, T-bet, GATA-3 and the possible remyelination properties were investigated in the central nervous system (CNS) by immunohistochemistry and Weigert-Pal-Russel’s method, respectively. Results: BCP group (50 mg/kg/day) showed a reduction of IL-17 in brain, cerebellum and medulla (p

Key words: β-Caryophyllene, multiple sclerosis, experimental autoimmune encephalomyelitis






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.